Molecules binding antigens, antibodies, antigesters of the network chain of the kb (RANKL) factor ligundamental ligundamental activant, methods of production, and pharmaceuticals containing them

VN10059442BActive Publication Date: 2026-07-15JIANGSU HENGRUI MEDICINE CO LTD +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: VN1202308631
Authority / Receiving Office: VN · VN
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2022-05-12
Publication Date: 2026-07-15
Estimated Expiration: 2042-05-12

Application Information

Patent Timeline

12 May 2022

Application

VN1202308631

15 Jul 2026

Publication

VN10059442B

Inventors: YING, Hua; MAO, Langyong

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to a molecule that binds to antigens specifically targeting RANKL and NGFh. Specifically, the invention relates to a novel anti-RANKL antibody, a dual-specific antibody targeting RANKL and NGFh, and a method for generating the antibody.

Need to check novelty before this filing date? Find Prior Art